| Lyan Gondin Hernandez, MD | |
|
10650 W State Road 84 Ste 206, Davie, FL 33324-4235 | |
| (954) 625-6778 | |
| (877) 404-6043 |
| Full Name | Lyan Gondin Hernandez |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 16 Years |
| Location | 10650 W State Road 84 Ste 206, Davie, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376920959 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | ME148706 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arnaldo Villafranca Md Pa | 7012149719 | 4 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same.
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
A new study by Florida State University researchers has found that people who were verbally abused as children grow up to be self-critical adults prone to depression and anxiety.
› Verified 4 days ago
| Entity Name | Arnaldo Villafranca Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437571965 PECOS PAC ID: 7012149719 Enrollment ID: O20140411000661 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same.
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
A new study by Florida State University researchers has found that people who were verbally abused as children grow up to be self-critical adults prone to depression and anxiety.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lyan Gondin Hernandez, MD 680 N University Dr, Pembroke Pines, FL 33024-6738 Ph: (954) 241-4084 | Lyan Gondin Hernandez, MD 10650 W State Road 84 Ste 206, Davie, FL 33324-4235 Ph: (954) 625-6778 |
News Archive
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Cayston® (aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis patients with Pseudomonas aeruginosa. Cayston's safety and efficacy have not been established in pediatric patients below the age of 7, patients with forced expiratory volume in one second of less than 25 percent or greater than 75 percent predicted, or patients colonized with Burkholderia cepacia.
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same.
While our efforts to combat COVID-19 remain at the forefront of our day-to-day activities, the U.S. Food and Drug Administration also continues its work on a number of important public health issues and, in particular, the opioid crisis.
By exploiting an HIV protein that readily traverses cell membranes, Carnegie Mellon University scientists have developed a new way to introduce a gene-like molecule called a peptide nucleic acid (PNA) directly into live mammalian cells, including human embryonic stem (ES) cells.
A new study by Florida State University researchers has found that people who were verbally abused as children grow up to be self-critical adults prone to depression and anxiety.
› Verified 4 days ago
Dennis Howard Penzell, D.O. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3200 S University Dr, Davie, FL 33328 Phone: 954-262-4100 Fax: 954-262-3285 | |
Dr. David Milner, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5355 Stirling Rd Ste A, Davie, FL 33314 Phone: 954-583-9599 Fax: 954-678-5750 | |
Dr. Grigory Kliger, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5595 Orange Dr, Suite 206, Davie, FL 33314 Phone: 954-583-5099 | |
Dr. Jasjot Paul Singh, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 4478 Weston Rd, Davie, FL 33331 Phone: 954-406-2887 | |
Manjit Singh Gulati, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3105 N University Dr, Davie, FL 33024 Phone: 954-438-6080 Fax: 954-499-5599 | |
Sukhvinder Kaur Gulati, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3105 N University Dr, Davie, FL 33024 Phone: 954-438-6080 Fax: 954-499-5599 | |
Evelyn A Schwalenberg, DO Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3200 S University Dr, Sanford L. Ziff Bldg., Davie, FL 33328 Phone: 954-262-4100 Fax: 954-262-2271 |